Breaking News Instant updates and real-time market news.

RXDX

Ignyta

$5.56

-0.04 (-0.71%)

10:45
10/17/16
10/17
10:45
10/17/16
10:45

Ignyta has a conference call hosted by JPMorgan

JPMorgan Analysts Kasimov, Fye and Rama will host a conference call with CEO Jonathan Lim and CFO Jacob Chacko on October 17 at 11 am.

  • 17

    Oct

  • 06

    Nov

  • 29

    Nov

RXDX Ignyta
$5.56

-0.04 (-0.71%)

06/23/16
JPMS
06/23/16
INITIATION
Target $15
JPMS
Overweight
Ignyta initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Ignyta with an Overweight rating and $15 price target, saying the company's lead program entrectinib is underappreciated from both a clinical and commercial perspective. Rama also views taladegib and RXDX-105 as interesting assets and potential long-term value drivers, though they are not currently included in the valuation model used to arrive at the $15 target.
05/11/16
PIPR
05/11/16
NO CHANGE
Target $32
PIPR
Overweight
Piper still surprised by Ignyta's 'modest valuation'
Piper Jaffray analyst Joshua Schimmer says he remains surprised by Ignyta's "modest valuation" given the company's "multiple attractive assets." Ignyta reported Q1 results last night provided some useful updates on entrectinib and taladegib, Schimmer tells investors in a research note. He keeps an Overweight rating on the shares with a $32 price target.
04/18/16
LEER
04/18/16
NO CHANGE
LEER
Outperform
Ignyta entrectinib continues to show 'encouraging' efficacy, says Leerink
Leerink analyst Paul Matteis says Ignyta's (RXDX) entrectinib continues to show "encouraging" efficacy and safety in an expanding sample of treated patients, following updated Phase 1 data presented by the company. The analyst says entrectinib shows "strong efficacy" in ROS1 with an 86% response rate, an 85% response rate in non-small cell lung cancer and multiple responses past 18 months. Loxo Oncology's (LOXO) LOXO-101, a competing inhibitor, also showed "nice efficacy data" with a comparable response rate, Matteis tells investors in a research note. The analyst reiterates an Outperform rating on Ignyta's shares.
04/18/16
PIPR
04/18/16
NO CHANGE
Target $32
PIPR
Overweight
Ignyta remains a top pick at Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Ignyta (RXDX) remains a top pick after the company over the weekend reported additional data from the ongoing entrectinib Phase 1 ALKA and STARTRK studies. The data continue to highlight the clinical activity in solid tumors as well as a generally tolerable profile, Schimmer tells investors in a research note. Loxo Oncology (LOXO) also reported Phase 1 data for an NTRK inhibitor, and the two drugs "appear fairly similar," the analyst contends. Schimmer believes this should help drive positive sentiment for Ignyta since there was investor concern that the Loxo data would appear superior. He keeps an Overweight rating on Ignyta with a $32 price target.

TODAY'S FREE FLY STORIES

CATM

Cardtronics

$29.27

0.16 (0.55%)

13:09
09/25/17
09/25
13:09
09/25/17
13:09
Recommendations
Cardtronics analyst commentary  »

Cardtronics selloff feels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATM

Cardtronics

$29.27

0.16 (0.55%)

13:05
09/25/17
09/25
13:05
09/25/17
13:05
Recommendations
Cardtronics analyst commentary  »

Cardtronics selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$111.78

-0.51 (-0.45%)

13:05
09/25/17
09/25
13:05
09/25/17
13:05
Options
Autodesk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$40.85

0.35 (0.86%)

12:59
09/25/17
09/25
12:59
09/25/17
12:59
Conference/Events
America's Car-Mart management to meet with Sidoti »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

NAV

Navistar

$41.68

0.35 (0.85%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:58
09/25/17
09/25
12:58
09/25/17
12:58
Periodicals
Navistar, Volkswagen Truck to launch electric medium duty truck, Reuters reports »

Navistar International…

NAV

Navistar

$41.68

0.35 (0.85%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Recommendations
Intercept analyst commentary  »

Intercept recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

YNDX

Yandex

$33.20

0.57 (1.75%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Options
Yandex put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUS

ePlus

$88.60

1.05 (1.20%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
ePlus management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PKY

Parkway

$23.04

0.02 (0.09%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
Parkway to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

, UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

12:50
09/25/17
09/25
12:50
09/25/17
12:50
Periodicals
Sen. Ted Cruz still opposes Graham-Cassidy bill, Axios reports »

Senator Ted Cruz remains…

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

CNC

Centene

$90.60

-1.62 (-1.76%)

WCG

WellCare

$165.67

-1.49 (-0.89%)

CI

Cigna

$181.69

-1.05 (-0.57%)

ANTM

Anthem

$182.89

0.03 (0.02%)

HNT

Health Net

HUM

Humana

$238.48

-0.6125 (-0.26%)

AET

Aetna

$152.55

-1.02 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SOL

ReneSola

$2.17

-0.0508 (-2.29%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Hot Stocks
ReneSola agrees to disposition of manufacturing, LED distribution units »

ReneSola announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEX

Alexander & Baldwin

$45.23

0.26 (0.58%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Conference/Events
Alexander & Baldwin management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

FB

Facebook

$170.54

-0.57 (-0.33%)

12:47
09/25/17
09/25
12:47
09/25/17
12:47
Periodicals
China blocks WhatsApp ahead of Communist Party gathering, NY Times reports »

China has mostly blocked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

HES

Hess Corp.

$45.45

0.95 (2.13%)

12:45
09/25/17
09/25
12:45
09/25/17
12:45
Options
Hess Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

C

Citi

$70.60

-0.8 (-1.12%)

12:43
09/25/17
09/25
12:43
09/25/17
12:43
Hot Stocks
Citibank, CGML ordered to pay $550,000 penalty by CFTC »

The U.S. Commodity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

UFPI

Universal Forest

$94.65

2.47 (2.68%)

12:41
09/25/17
09/25
12:41
09/25/17
12:41
Conference/Events
Universal Forest management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

NAV

Navistar

$42.09

0.755 (1.83%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Periodicals
Breaking Periodicals news story on Navistar, Volkswagen »

Navistar, Volkswagen…

NAV

Navistar

$42.09

0.755 (1.83%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

DRI

Darden

$82.45

-0.43 (-0.52%)

, FDS

FactSet

$167.38

-1.23 (-0.73%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$82.45

-0.43 (-0.52%)

FDS

FactSet

$167.38

-1.23 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

NAV

Navistar

$42.05

0.72 (1.74%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:39
09/25/17
09/25
12:39
09/25/17
12:39
Hot Stocks
Navistar announces collaboration with Volkswagen Truck & Bus »

Navistar (NAV) announced…

NAV

Navistar

$42.05

0.72 (1.74%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

F

Ford

$11.88

0.035 (0.30%)

12:38
09/25/17
09/25
12:38
09/25/17
12:38
Periodicals
NFL sponsor Ford issues statement supporting free speech, Bloomberg says »

Following a string of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

  • 26

    Oct

BGG

Briggs & Stratton

$22.70

0.01 (0.04%)

12:35
09/25/17
09/25
12:35
09/25/17
12:35
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:34
09/25/17
09/25
12:34
09/25/17
12:34
Recommendations
Intercept analyst commentary  »

Jefferies cuts Intercept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

, MKGAY

Merck KGaA

12:33
09/25/17
09/25
12:33
09/25/17
12:33
Hot Stocks
Lufthansa chairman Mayrhuber resigns, Kley named new chairman »

Prior to today's…

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

MKGAY

Merck KGaA

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAWW

Atlas Air

$67.60

0.15 (0.22%)

12:32
09/25/17
09/25
12:32
09/25/17
12:32
Hot Stocks
Atlas Air, Polar Air Cargo seek preliminary injunction to stop work slowdown »

Atlas Air and Polar Air…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIN

Albany International

$55.80

-0.45 (-0.80%)

12:31
09/25/17
09/25
12:31
09/25/17
12:31
Conference/Events
Albany International management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.